WestView Capital Partners has completed a strategic minority investment in Helio Health Group, according to a news release.
HELIO, founded in 2015 and based in Morristown, New Jersey, is a life sciences consulting and technology firm providing compliance, government pricing and commercial services to pharmaceutical and biotechnology companies, including AI-enabled software solutions.
WestView, founded in 2004 and based in Boston, is focused on investing in middle market companies in several sectors, including healthcare technology and outsourcing. The firm pursues minority and majority recapitalizations, growth, and consolidation transactions.
Terms of the investment were not disclosed.